Topos Bio Emerges from Stealth to Tackle Disordered Proteins with $10.5M and Frontier AI
What You Should Know – Topos Bio has emerged from stealth with $10.5M in seed funding to solve one of the most persistent challenges in medicine: targeting intrinsically disordered proteins (IDPs). The seed funding was led by Boldstart, Threshold, and Neo, with participation from notable angel investors including Dara Khosrowshahi (CEO of Uber) and Naveen Rao ... Read More